GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Debt-to-Revenue

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Debt-to-Revenue : 0.28 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Integrated Diagnostics Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $6.00 Mil. Integrated Diagnostics Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $22.61 Mil. Integrated Diagnostics Holdings's annualized Revenue for the quarter that ended in Mar. 2024 was $103.77 Mil. Integrated Diagnostics Holdings's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.28.


Integrated Diagnostics Holdings Debt-to-Revenue Historical Data

The historical data trend for Integrated Diagnostics Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Debt-to-Revenue Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.21 0.16 0.33 0.29

Integrated Diagnostics Holdings Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.04 0.03 N/A 0.28

Competitive Comparison of Integrated Diagnostics Holdings's Debt-to-Revenue

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Diagnostics Holdings's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's Debt-to-Revenue falls into.



Integrated Diagnostics Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Integrated Diagnostics Holdings's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(7.13 + 31.018) / 133.367
=0.29

Integrated Diagnostics Holdings's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(6.002 + 22.611) / 103.768
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Integrated Diagnostics Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
12 Castle Street, Saint Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN 09-24-2021